Rapporto annuale 2007 - Istituto di Ricerche Farmacologiche Mario ...
Rapporto annuale 2007 - Istituto di Ricerche Farmacologiche Mario ...
Rapporto annuale 2007 - Istituto di Ricerche Farmacologiche Mario ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
IRFMN<br />
Principali pubblicazioni<br />
• Tripo<strong>di</strong>, A., Chantarangkul, V., Bohm, M., Budde, U., Dong, J.-F., Friedman, K.D., Galbusera, M., Girma, J.-P., Moake,<br />
J., Rick, M.E., Studt, J.-D., Turecek, P.L., Mannucci, P.M.: Measurement of von Willebrand factor cleaving protease<br />
(ADAMTS-13): results of an international collaborative study involving 11 methods testing the same set of coded<br />
plasmas. J Thromb Haemost 2004; 2:1601-1609.<br />
• Galbusera, M., Morigi, M., Buelli, S., Gastol<strong>di</strong>, S., Macconi, D., Testa, C., Angioletti, S., Remuzzi, G.: Xenogeneic<br />
serum-induced thrombus formation on porcine endothelium is me<strong>di</strong>ated by vitronectin receptor and P-selectin: role of<br />
reactive oxygen species. Xenotransplantation 2005;12:110-120.<br />
• Ruiz-Torres, M.P., Casiraghi, F., Galbusera, M., Macconi, D., Gastol<strong>di</strong>, S., Todeschini, M., Porrati, F., Belotti, D.,<br />
Pogliani, E.M., Noris, M., Remuzzi, G.: Complement activation: the missing link between ADAMTS13 deficiency and<br />
microvascular thrombosis of thrombotic microangiopathies. Thromb Haemost 2005; 93:443-452.<br />
• Noris, M., Bucchioni, S., Galbusera, M., Donadelli, R., Bresin, E., Castelletti, F., Caprioli, J., Brioschi, S., Scheiflinger,<br />
F., Remuzzi, G.: Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13<br />
deficiency and renal involvement. J Am Soc Nephrol 2005; 16:1177-1183.<br />
• Galbusera, M., Bresin, E., Noris, M., Gastol<strong>di</strong>, S., Belotti, D., Capoferri, C., Daina, E., Perseghin, P., Scheiflinger, F.,<br />
Fakhouri, F., Grunfeld, J-P., Pogliani, E., Remuzzi, G.: Rituximab prevents recurrence of thrombotic thrombocytopenic<br />
purpura: a case report. Blood 2005;106:925-928.<br />
• Rieger, M., Mannucci, P.M., Kremer Hovinga, J.A., Herzog, A., Gerstenbauer, G., Konetschny, C., Zimmermann, K.,<br />
Scharrer, I., Peyvan<strong>di</strong>, F., Galbusera, M., Remuzzi, G., Böhm, M., Plaimauer, B., Lämmle, B., Scheiflinger, F.:<br />
ADAMTS13 autoantibo<strong>di</strong>es in patients with thrombotic microangiopathies and other immunome<strong>di</strong>ated <strong>di</strong>seases. Blood<br />
2005;106:1262-1267.<br />
Susanna Tomasoni si è laureata in Scienze Biologiche nel 1991 presso l’Università degli Stu<strong>di</strong> <strong>di</strong><br />
Milano.<br />
Attività formative: nel 1989-1991 Studente tesista, Università degli Stu<strong>di</strong> <strong>di</strong> Milano; nel 1991-1994<br />
Studente <strong>di</strong> dottorato, Università degli Stu<strong>di</strong> <strong>di</strong> Milano; nel 1994 Borsista, Renal Division, Brigham &<br />
Women’s Hospital, Harvard Me<strong>di</strong>cal School, Boston, USA; nel 1995 Titolo <strong>di</strong> Dottore in Ricerca in<br />
Scienze Fisiologiche, Università <strong>di</strong> Bologna; nel 1995-1998 Borsista, IRFMN, Bergamo.<br />
Aree <strong>di</strong> interesse: costruzione <strong>di</strong> vettori adenovirali per terapia genica; trasferimento genico al rene nel<br />
contesto del trapianto; trasfezione <strong>di</strong> cellule dendritiche per terapia cellulare applicata al trapianto;<br />
progressione delle malattie renali.<br />
Ruoli: 1998-2000: Ricercatrice, IRFMN, Bergamo. Dal 2000: Capo Unità <strong>di</strong> terapia genica, IRFMN,<br />
Bergamo.<br />
Principali pubblicazioni:<br />
• Tomasoni S, Azzollini N, Casiraghi F, Capogrossi M C, Remuzzi G, Benigni A. CTLA4Ig gene transfer prolongs<br />
survival and induces donor-specific tolerance in a rat renal allograft. J Am Soc Nephrol 2000; 11: 747-752.<br />
• Tomasoni S, Benigni A. Gene therapy: How to target the kidney. Promises and pitfalls. Curr Gene Ther 2004; 4: 115-<br />
122.<br />
• Tomasoni S, Longaretti L, Azzollini N, Gagliar<strong>di</strong>ni E, Mister M, Buehler T, Remuzzi G, Benigni A. Favorable effect of<br />
cotransfection with TGF-beta and CTLA4Ig of the donor kidney on allograft survival. Am J Nephrol 2004; 24: 275-283<br />
• Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, Rottoli D, Angioletti S, Benigni A, Perico N, Alison<br />
M, Remuzzi G. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal<br />
failure. J Am Soc Nephrol 2004; 15: 1794-1804<br />
• Tomasoni S, Aiello S, Cassis L, Noris M, Longaretti L, Cavinato R, Azzollini N, Pezzotta A, Remuzzi G, Benigni A.<br />
Dendritic cells genetically engineered with adenoviral vector enco<strong>di</strong>ng dnIKK2 induce the formation of potent CD4+ T-<br />
regulatory cells. Transplantation 2005; 79: 1056-1061.<br />
• Benigni A, Tomasoni S, Turka LA, Longaretti L, Zentilin L, Mister M, Pezzotta A, Azzollini N, Noris M, Conti S,<br />
Abbate M, Giacca M, Remuzzi G, Adeno-associated virus-me<strong>di</strong>ated CTLA4Ig gene transfer protects MHC-mismatched<br />
renal allografts from chronic rejection. J Am Soc Nephrol, 2006, 17: 1665-72.<br />
253<br />
RAPPORTO ATTIVITA’ <strong>2007</strong>